id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2005-N-0099-0017,FDA,FDA-2005-N-0099,"Transcript of the November 14, 2005 meeting",Other,TR-Transcript,2005-12-15T05:00:00Z,2005,12,,,2008-04-11T23:50:03Z,,0,0,090000648043f859
FDA-2005-N-0099-0011,FDA,FDA-2005-N-0099,"Director, Center for Drug Evaluation and Research, FDA",Other,TS-Testimony,2005-12-07T05:00:00Z,2005,12,,,2008-04-11T23:50:04Z,,0,0,090000648043f828
FDA-2005-N-0099-0012,FDA,FDA-2005-N-0099,"Director, Center for Drug Evaluation and Research, FDA",Other,TS-Testimony,2005-12-07T05:00:00Z,2005,12,,,2008-04-11T23:50:03Z,,0,0,090000648043f829
FDA-2005-N-0099-0005,FDA,FDA-2005-N-0099,"Agenda for November 14, 25005 FDA and Stateholders Public Meeting",Other,LST-List,2005-12-07T05:00:00Z,2005,12,,,2008-04-11T23:50:03Z,,0,0,090000648043f822
FDA-2005-N-0099-0013,FDA,FDA-2005-N-0099,"Director, Center for Biologics Evaluation and Research, FDA",Other,TS-Testimony,2005-12-07T05:00:00Z,2005,12,,,2008-04-11T23:50:03Z,,0,0,090000648043f82a
FDA-2005-N-0099-0015,FDA,FDA-2005-N-0099,"Deputy Commissioner for Policy, FDA",Other,TS-Testimony,2005-12-07T05:00:00Z,2005,12,,,2008-04-11T23:50:03Z,,0,0,090000648043f839
FDA-2005-N-0099-0016,FDA,FDA-2005-N-0099,"Deputy Commissioner for Policy, FDA",Other,TS-Testimony,2005-12-07T05:00:00Z,2005,12,,,2008-04-11T23:50:03Z,,0,0,090000648043f83a
FDA-2005-N-0099-0014,FDA,FDA-2005-N-0099,"Director, Center for Biologics Evaluation and Research, FDA",Other,TS-Testimony,2005-12-07T05:00:00Z,2005,12,,,2008-04-11T23:50:03Z,,0,0,090000648043f82b
FDA-2005-N-0099-0008,FDA,FDA-2005-N-0099,"Biographies for November 14, 2005 Meeting",Other,LST-List,2005-12-07T05:00:00Z,2005,12,,,2008-04-11T23:50:03Z,,0,0,090000648043f825
FDA-2005-N-0099-0007,FDA,FDA-2005-N-0099,"Biographies for November 14, 2005 Meeting",Other,LST-List,2005-12-07T05:00:00Z,2005,12,,,2008-04-11T23:50:03Z,,0,0,090000648043f824
FDA-2005-N-0099-0006,FDA,FDA-2005-N-0099,"Agenda for November 14, 25005 FDA and Stateholders Public Meeting",Other,LST-List,2005-12-07T05:00:00Z,2005,12,,,2008-04-11T23:50:03Z,,0,0,090000648043f823
FDA-2005-N-0099-0009,FDA,FDA-2005-N-0099,"Deputy Commissioner for Operations, FDA",Other,TS-Testimony,2005-12-07T05:00:00Z,2005,12,,,2008-04-11T23:50:03Z,,0,0,090000648043f826
FDA-2005-N-0099-0010,FDA,FDA-2005-N-0099,"Deputy Commissioner for Operations, FDA",Other,TS-Testimony,2005-12-07T05:00:00Z,2005,12,,,2008-04-11T23:50:03Z,,0,0,090000648043f827
FDA-2005-N-0099-0002,FDA,FDA-2005-N-0099,FDA,Notice,NCR-Notice of Correction,2005-11-07T05:00:00Z,2005,11,2005-10-27T04:00:00Z,,2008-04-11T23:50:04Z,,0,0,090000648043f81b
FDA-2005-N-0099-0001,FDA,FDA-2005-N-0099,FDA,Notice,NM-Notice of Meeting,2005-10-18T04:00:00Z,2005,10,2005-10-14T04:00:00Z,2005-12-15T04:59:59Z,2008-04-11T23:50:03Z,,0,0,090000648043f811